CBD Life Sciences Inc (CBDL)

[Batman412]

Big news coming two partnerships let's go still waiting on army 

[packerfan9]

Probably never. Once they dilute billions. It will end up at .0001 like before the r/s. Then question is will another r/s be approved. As long as fools keep buying. They will keep selling new shares. No one at these levels as a gain to sell. Only the company is filling buys.

[GoonOfWallSt]

When will this junk pos scam be delisted and revoked?

[packerfan9]

Wrong news was another increase in A/S. So much for the share buyback lie. Buying this makes you the DS.

[packerfan9]

They increased the A/S again.

[Batman412]

There was no pr today dipshit

[Batman412]

Did I miss something what pr dropped today what are you talking about 

[packerfan9]

The Pr today is more added dilution. So much for the lie about a share buyback.

[stock king 1]

I hear she a real twat

[packerfan9]

Rumor? Fact. Since 2020 they have dumped on presplit basis. Trillions of shares. They said share buyback this year. Then increased a/s to 8.5 billion. What did the company have to show for all this dilution? Last filing showed 167,000 in revenues. She got rich selling shares not CBD. Fools still buying new shares daily.

[stock king 1]

When the next huge R/S . Wash rinse and repeat .

[stock king 1]

Rumor has it this ceo a real pile of chit crook .

[packerfan9]

Really foolish when they have tiny sales and are filling buys with new shares every day. That anyone believed that blatant lie about a buyback. In the past they have said no more dilution. Then increased A/S and did more. They can keep doing it as more fools show up every time.

[stock king 1]

Buy back too funny these lying piece of chits …. Same ole bull chit lies with this continued scam

[stock king 1]

Ceo a real piece of shit

[packerfan9]

8.5 billion new shares to be issued. I told people they never stop diluting and the buyback was a lie. Every day shares sold is dilution and that never changes. This will be at .0001 even sooner to sell all these.

CBD Life Sciences, Inc.
8,400,000,000 Shares of Common Stock
This Post-Qualification Offering Circular Amendment No. 3 amends the Offering Circular of CBD Life Sciences, Inc., a Nevada corporation (the “Company”), dated June 24, 2024, as qualified on June 21, 2024, and Post-Qualification Amendment No. 2 as filed on September 6, 2024, as qualified on September 17, 2024, and as may be amended and supplemented from time to time, to: (a) extend the expiration date of this offering to February 28, 2026; (b) to add 3,900,000,000 additional shares of common stock to the offered by this Offering Circular, for a revised maximum of 8,400,000,000 shares (collectively, the “Offered Shares”); and (c) to revise the offering price of the 6,687,062,556 shares of Company common stock that remain unsold (the “Remaining Shares”) to $__[0.0001-0.0006].



By this Offering Circular, the Company is offering for sale a maximum of 8,500,000,000 shares of its common stock (the Offered Shares), of which 1,478,666,729 shares have been sold for cash in the total amount of $696,310 and of which 6,687,062,556 shares, the Remaining Shares, at a fixed price of $__[0.0001-0.0006] per share, pursuant to Tier 1 of Regulation A of the United States Securities and Exchange Commission (the “SEC”). A minimum purchase of $5,000 of the Offered Shares is required in this offering; any additional purchase must be in an amount of at least $1,000. This offering is being conducted on a best-efforts basis, which means that there is no minimum number of Offered Shares that must be sold by us for this offering to close; thus, we may receive no or minimal proceeds from this offering. All proceeds from this offering will become immediately available to us and may be used as they are accepted. Purchasers of the Offered Shares will not be entitled to a refund and could lose their entire investments.

[packerfan9]

Wrong. How blind can you be? The share buy back was a lie. The dilution never ends. This will get stuck at .00001 yet again.

[packerfan9]

When they dilute this down to .00001 again. Then if not selling enough shares. Then another r/s. They have again got too many new suckers to by shares. Only thing that will prevent another r/s. They done a few already the last 5 years.

[stock king 1]

Huge rs coming . What a pile this company is .

[konshe]

0.0004 looks like a good buy.

[stock king 1]

Yes ceo she really full of chit

[stock king 1]

Yes ceo she really full of chit

[packerfan9]

At some point after she drives it back to .00001 like before this r/s. The company only survives by selling shares. The revenues are so tiny. They have been selling billions of shares and on pre r/s basis trillions. Never stopped for over 5 years. Never will. They get rich selling shares not CBD. As the tiny sales show. Buy Back is all lies as they have no money to buy with. They fill buys every day with new shares.

[stock king 1]

This pile of chit ceo going to rs this garbage again disgusting crooked ceo . Imho

[Livelikenotommorow]

Just your typical OTC pump and dump we need them to get there head out of there rears and come up with some better pumps because what they been preaching is pretty bad .

[packerfan9]

More dilution daily at these levels. Wait until the next filing. They only make money selling shares not CBD. Revenues are still tiny.

[Chartmaster]

BD Life Sciences Inc. (CBDL) Launches Mushroom Powder CapsulesPress Release | 02/26/2025

The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!

SCOTTSDALE, ARIZONA / ACCESSWIRE / February 26, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making a bold move into the multi-billion-dollar functional mushroom market with the official launch of its Mushroom Powder Capsules-a powerful, all-natural supplement designed to elevate brain function, enhance energy, boost immunity, and optimize overall wellness.

This premium formulation combines five of the most researched and revered medicinal mushrooms:

Lion's Mane - Known for its neuroprotective properties, enhances cognitive function, memory, and focus.

Cordyceps - Increases stamina, improves athletic performance, and supports lung function.

Reishi - Helps reduce stress, promotes better sleep, and strengthens the immune system.

Maitake - Supports metabolic health and helps regulate blood sugar levels.

Turkey Tail - Packed with antioxidants and polysaccharides that fortify gut health and boost immunity.

With scientific studies confirming the vast health benefits of these mushrooms, CBDL is positioning itself at the forefront of the natural health revolution. The global demand for functional mushrooms has skyrocketed due to their ability to combat stress, enhance brain power, and promote longevity-aligning perfectly with consumer trends toward holistic wellness and plant-based supplementation.

A Massive Revenue Opportunity

By launching into the functional mushroom industry, CBDL is tapping into a market projected to exceed $19 billion by 2030, with a CAGR of 9.1%. This strategic expansion will drive substantial new revenue streams and significantly increase consumer engagement with the brand.

CBDL's Mushroom Powder Capsules will be available through its existing sales channels, including direct-to-consumer e-commerce and select retail partners, with further distribution expansion planned as demand grows.

"This launch marks a pivotal moment for CBDL as we expand beyond CBD and into the booming functional mushroom sector," said Lisa Nelson, CEO of CBD Life Sciences Inc. "Our goal is to provide top-tier, science-backed natural solutions that enhance everyday health while capitalizing on one of the fastest-growing wellness trends in the world."

CBDL is committed to aggressive marketing, expanding its direct sales reach, and forming strategic partnerships to position its Mushroom Powder Capsules as a category leader. With consumer interest surging and scientific validation mounting, CBDL's foray into functional mushrooms represents not just an innovative product launch-but a major step toward long-term profitability and market dominance.

About CBD Life Sciences Inc.

CBD Life Sciences Inc. (OTC:CBDL) is a leading innovator in the CBD and natural health industry, dedicated to developing high-quality, science-backed products that enhance wellness and vitality. With a growing portfolio spanning CBD topicals, edibles, and now functional mushrooms, CBDL continues to push boundaries in holistic health solutions.

For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [e-mail]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz

Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[e-mail]
4802091720

SOURCE: CBD Life Sciences, Inc.


View the original press release on accesswire.com
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Launches-Mushroom-Powder-Capsules?id=468863

[AveragePenny]

$CBDL CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc-cbdl-launches-mushroom-powder-capsules-991624

The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!

SCOTTSDALE, ARIZONA / ACCESS Newswire / February 26, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making a bold move into the multi-billion-dollar functional mushroom market with the official launch of its Mushroom Powder Capsules-a powerful, all-natural supplement designed to elevate brain function, enhance energy, boost immunity, and optimize overall wellness.

This premium formulation combines five of the most researched and revered medicinal mushrooms:

Lion's Mane - Known for its neuroprotective properties, enhances cognitive function, memory, and focus.

Cordyceps - Increases stamina, improves athletic performance, and supports lung function.

Reishi - Helps reduce stress, promotes better sleep, and strengthens the immune system.

Maitake - Supports metabolic health and helps regulate blood sugar levels.

Turkey Tail - Packed with antioxidants and polysaccharides that fortify gut health and boost immunity.

With scientific studies confirming the vast health benefits of these mushrooms, CBDL is positioning itself at the forefront of the natural health revolution. The global demand for functional mushrooms has skyrocketed due to their ability to combat stress, enhance brain power, and promote longevity-aligning perfectly with consumer trends toward holistic wellness and plant-based supplementation.

A Massive Revenue Opportunity

By launching into the functional mushroom industry, CBDL is tapping into a market projected to exceed $19 billion by 2030, with a CAGR of 9.1%. This strategic expansion will drive substantial new revenue streams and significantly increase consumer engagement with the brand.

CBDL's Mushroom Powder Capsules will be available through its existing sales channels, including direct-to-consumer e-commerce and select retail partners, with further distribution expansion planned as demand grows.

"This launch marks a pivotal moment for CBDL as we expand beyond CBD and into the booming functional mushroom sector," said Lisa Nelson, CEO of CBD Life Sciences Inc. "Our goal is to provide top-tier, science-backed natural solutions that enhance everyday health while capitalizing on one of the fastest-growing wellness trends in the world."

CBDL is committed to aggressive marketing, expanding its direct sales reach, and forming strategic partnerships to position its Mushroom Powder Capsules as a category leader. With consumer interest surging and scientific validation mounting, CBDL's foray into functional mushrooms represents not just an innovative product launch-but a major step toward long-term profitability and market dominance.

[RedSox04]

News out! https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Launches-Mushroom-Powder-Capsules?id=468863

[packerfan9]

Run hard LOL. The sales after 5 years are tiny. They have no money for a buy back. They make money selling shares. Same as before and after r/s. They are the ones fill buys.

[packerfan9]

Buyback? Were do you think at these levels buys are filled? From new shares. They have tiny sales no money. Wait and see. This is same as it always been. Lies, little sales and big dilution. To ignore the 5 years of the same. Just a blind fool.

[Batman412]

Any loi's close this could run too 

[Batman412]

Could run hard here does open buyback mean there will be form 4s 

[Batman412]

4.5 million at .0006 lfg 

[packerfan9]

If you really believe the lies. Buy more. LOL.

[packerfan9]

Finally got smart. That is only way to make money with how bad dilution is here.

[RickRat]

News – Looks Good
https://www.otcmarkets.com/stock/CBDL/news/CBDL-Launches-New-Mushroom-Supplement-Drink--Smoothie-Bar?id=468080

[RickRat]

6's almost gone
7's will go quick
8 - 10 by EOD
Then Monday = ??

[RickRat]

Thinning Ask
Only 50K at .0006
This is getting ready to move.

[konshe]

sold out at 0.0006 with 50% profits, put money in RDGL. CBDL is still doing dilution, not buy back, that's why I leave.

[stock king 1]

Correct Lisa the ceo she a liar and con . Only 3 employees disgusting the crap she trying to sell good luck

[packerfan9]

The company has tiny sales after 5 years of this dilution scam. That anyone thinks they will buy back shares. They are selling them and always have.

[GoonOfWallSt]

Pile of junk diluting pig. When next r/s?

[packerfan9]

Not yet. They will just keep diluting until like bef0ore last r/s. Until it gets stuck at .00001 again. They will just keep filling buys. At these levels few shareholders have gains.

[stock king 1]

Rumor has it Lisa was giving tons of shares to pump this . You all are getting played by this women she doesn’t have any thing solid …..

[stock king 1]

Ceo Lisa answer the phone shareholders have questions on your bull shit

[stock king 1]

Watch for a huge rs coming . This how they wash rinse and repeat . Three employees and they can’t answer the phone bunch of crooks .

[stock king 1]

I strong believe Lisa full of chit and just selling bull chit . Called many times

[stock king 1]

These fuckers don’t answer the phone let alone 3 employees

[konshe]

Mo need to R/S, CEO should stop dilution, and begin to buy back shares to push the PPS take off.